Director William R. Shepard buys more shares as CME Group stock rises

  • CME Group stock outperformed the S&P 500 in 2023
  • Director William R. Shepard bought more shares
  • CME stock logged a 25% gain last year
  • Shepard purchased 1,390 shares at an average price of $202.44 each
  • Shepard now owns a total of 253,060 shares

CME Group, the parent company of the Chicago Mercantile Exchange, saw its stock outperform the broader market in 2023. Director William R. Shepard showed confidence in the company by purchasing more shares. CME stock recorded a 25% gain, surpassing the 24% rise in the S&P 500 index. Shepard bought a total of 1,390 shares at an average price of $202.44 each. He now owns a total of 253,060 shares. Shepard, a longtime director of CME, is also the founder and president of Shepard International. His purchase reflects his continued belief in the company’s prospects.

Public Companies: CME Group (CME)
Private Companies:
Key People: William R. Shepard (Director)

Track all markets on TradingView

Factuality Level: 8
Justification: The article provides factual information about the rise in CME Group stock in 2023 and the purchase of shares by director William R. Shepard. The information is supported by the filing with the Securities and Exchange Commission. There are no obvious digressions, misleading information, sensationalism, or opinion masquerading as fact. The article does not contain any bias or personal perspective. However, it is relatively short and lacks in-depth analysis or additional context.

Noise Level: 3
Justification: The article provides information about the rise in CME Group stock and the purchase of shares by director William R. Shepard. However, the article lacks context and analysis, and does not provide any actionable insights or new knowledge for the reader.

Financial Relevance: Yes
Financial Markets Impacted: CME Group stock

Presence of Extreme Event: No
Nature of Extreme Event: No
Impact Rating of the Extreme Event: No
Justification: The article pertains to the financial market as it discusses the rise in CME Group stock and the purchase of shares by a director.

Reported publicly: www.marketwatch.com